Greg Harrison

Stock Analyst at B of A Securities

(4.48)
# 269
Out of 5,182 analysts
106
Total ratings
56.79%
Success rate
20.9%
Average return

Stocks Rated by Greg Harrison

Agios Pharmaceuticals
Apr 21, 2026
Maintains: Buy
Price Target: $44$41
Current: $24.80
Upside: +65.32%
United Therapeutics
Mar 31, 2026
Maintains: Neutral
Price Target: $569$626
Current: $569.11
Upside: +10.00%
Mineralys Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $46$51
Current: $25.89
Upside: +96.99%
Vertex Pharmaceuticals
Feb 13, 2026
Maintains: Sector Perform
Price Target: $495$558
Current: $430.14
Upside: +29.73%
Intellia Therapeutics
Oct 27, 2025
Maintains: Buy
Price Target: $36$30
Current: $13.20
Upside: +127.27%
Travere Therapeutics
Aug 7, 2025
Maintains: Sector Outperform
Price Target: $30$31
Current: $40.89
Upside: -24.19%
Ocular Therapeutix
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $22$20
Current: $9.32
Upside: +114.59%
BridgeBio Pharma
Aug 6, 2025
Maintains: Sector Outperform
Price Target: $55$57
Current: $69.71
Upside: -18.23%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Sector Outperform
Price Target: $342$450
Current: $302.11
Upside: +48.95%
Gossamer Bio
Jul 14, 2025
Initiates: Sector Outperform
Price Target: $11
Current: $0.34
Upside: +3,089.33%
Maintains: Sector Outperform
Price Target: $32$35
Current: $8.87
Upside: +294.59%
Maintains: Sector Outperform
Price Target: $65$55
Current: $37.11
Upside: +48.21%
Maintains: Sector Outperform
Price Target: $51$19
Current: $3.43
Upside: +453.94%
Maintains: Sector Outperform
Price Target: $36$37
Current: $37.65
Upside: -1.73%
Maintains: Sector Outperform
Price Target: $41$26
Current: $11.37
Upside: +128.67%
Maintains: Sector Perform
Price Target: $28$20
Current: $40.99
Upside: -51.21%
Downgrades: Sector Perform
Price Target: $4$1.5
Current: $1.51
Upside: -0.66%
Upgrades: Sector Outperform
Price Target: $40
Current: $30.56
Upside: +30.89%
Maintains: Sector Outperform
Price Target: $73$75
Current: $67.26
Upside: +11.51%
Initiates: Sector Outperform
Price Target: $18
Current: $13.47
Upside: +33.63%
Upgrades: Neutral
Price Target: $9$12
Current: $33.33
Upside: -64.00%
Downgrades: Underperform
Price Target: $5$1.5
Current: $0.20
Upside: +646.27%
Maintains: Neutral
Price Target: $18$15
Current: $3.06
Upside: +390.20%
Downgrades: Underperform
Price Target: $3
Current: $14.67
Upside: -79.55%
Initiates: Buy
Price Target: $70
Current: $0.96
Upside: +7,227.54%
Maintains: Buy
Price Target: $67$54
Current: $14.65
Upside: +268.60%
Downgrades: Underperform
Price Target: $270$90
Current: $83.81
Upside: +7.39%